• LAST PRICE
    1.9100
  • TODAY'S CHANGE (%)
    Trending Down-0.0600 (-3.0457%)
  • Bid / Lots
    1.9000/ 1
  • Ask / Lots
    2.1400/ 1
  • Open / Previous Close
    1.9700 / 1.9700
  • Day Range
    Low 1.8300
    High 1.9800
  • 52 Week Range
    Low 1.0600
    High 2.8500
  • Volume
    154,676
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 1.97
TimeVolumeSVRA
09:32 ET38491.94
09:39 ET11001.94
09:43 ET1001.92
09:50 ET1001.925
09:52 ET3001.92
09:54 ET10001.91
09:59 ET12001.9
10:01 ET1371.93
10:08 ET17581.915
10:10 ET6001.92
10:12 ET1001.915
10:15 ET52051.88
10:17 ET2541.89
10:21 ET7001.9
10:32 ET1001.9
10:33 ET190941.87
10:35 ET2001.9
10:42 ET3031.89
10:50 ET1001.8968
10:53 ET2301.89
10:55 ET17821.9
11:00 ET71001.9002
11:02 ET3001.9092
11:04 ET1001.905
11:06 ET29501.885
11:08 ET1001.8876
11:15 ET5001.8899
11:22 ET1001.885
11:24 ET5001.88
11:26 ET1001.875
11:27 ET7641.865
11:31 ET1311.8683
11:33 ET3361.86
11:36 ET8001.865
11:38 ET38401.84
11:42 ET3001.84
11:44 ET2361.83
11:45 ET23041.86
11:49 ET39191.86
11:51 ET1001.86
11:54 ET9651.87
11:56 ET100421.85
12:00 ET2001.85
12:03 ET21641.86
12:05 ET67761.86
12:07 ET1001.865
12:09 ET5001.86
12:12 ET6001.86
12:14 ET11111.86
12:16 ET2001.865
12:20 ET13741.85
12:23 ET1001.86
12:25 ET2001.86
12:27 ET1001.86
12:30 ET21851.88
12:32 ET3001.89
12:34 ET1001.89
12:36 ET1001.89
12:38 ET4001.885
12:39 ET2001.89
12:41 ET2001.89
12:43 ET3001.89
12:48 ET1001.885
12:50 ET4001.9
12:54 ET4051.9
12:56 ET1001.905
12:57 ET1001.905
12:59 ET2981.905
01:01 ET1001.905
01:03 ET17001.89
01:30 ET1001.89
01:39 ET33891.89
01:44 ET21341.92
01:46 ET8001.93
02:00 ET2001.94
02:02 ET2511.94
02:08 ET27001.96
02:13 ET1001.965
02:15 ET26481.96
02:18 ET2951.95
02:20 ET5161.95
02:24 ET2191.96
02:26 ET1001.97
02:29 ET14001.98
02:33 ET7251.98
02:36 ET5001.98
02:38 ET13241.96
02:42 ET3001.945
02:44 ET1541.95
02:47 ET1061.9621
03:00 ET15561.96
03:02 ET1001.96
03:03 ET7001.96
03:05 ET1001.96
03:07 ET1001.96
03:09 ET3001.96
03:20 ET23351.97
03:21 ET6001.97
03:23 ET1001.96
03:30 ET1451.96
03:32 ET3001.97
03:39 ET5001.96
03:41 ET11981.96
03:43 ET1001.96
03:48 ET12001.93
03:52 ET7321.9
03:54 ET12001.9
03:56 ET1001.89
03:57 ET17001.92
03:59 ET51261.91
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSVRA
Savara Inc
224.7M
-7.2x
---
United StatesOMER
Omeros Corp
224.9M
-1.2x
---
United StatesORIC
Oric Pharmaceuticals Inc
224.1M
-2.1x
---
United StatesCELC
Celcuity Inc
222.3M
-4.2x
---
United StatesGBIO
Generation Bio Co
232.7M
-1.6x
---
United StatesIMRX
Immuneering Corp
231.6M
-5.3x
---
As of 2023-03-22

Company Information

Savara Inc. is a clinical-stage biopharmaceutical company. The Company is focused on rare respiratory diseases. The Company’s lead program, molgramostim nebulizer solution (molgramostim), a inhaled biologic, is a granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of aPAP. Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the build-up of surfactant in the alveoli or air sacs of the lungs.

Contact Information

Headquarters
6836 BEE CAVE ROAD BUILDING 3, SUITE 201AUSTIN, TX, United States 78746
Phone
512-614-1848
Fax
858-552-0876

Executives

Chairman of the Board, Chief Executive Officer
Matthew Pauls
Chief Financial and Administrative Officer
David Lowrance
Chief Operating Officer
Robert Lutz
Chief Medical Officer
Raymond Pratt
Lead Independent Director
Joseph McCracken

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$224.7M
Revenue (TTM)
$0.00
Shares Outstanding
114.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.92
EPS
$-0.27
Book Value
$1.27
P/E Ratio
-7.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.